increas
burden
pneumonia
adult
emerg
health
issu
era
global
popul
age
studi
conduct
elucid
burden
communityonset
pneumonia
cop
etiolog
fraction
japan
world
age
societi
multicent
prospect
surveil
cop
conduct
septemb
januari
japan
pneumonia
patient
age
year
includ
communityacquir
pneumonia
cap
health
careassoci
pneumonia
hcap
enrol
four
commun
hospit
four
major
island
cop
burden
estim
base
surveil
data
nation
statist
total
cop
episod
hospit
visit
enrol
surveil
estim
overal
incid
rate
adult
cop
hospit
inhospit
death
confid
interv
per
personyear
py
respect
incid
rate
sharpli
increas
age
incid
peopl
age
year
higher
peopl
age
year
estim
annual
number
adult
cop
case
entir
japanes
popul
age
year
aspirationassoci
pneumonia
lead
etiolog
categori
follow
streptococcu
pneumoniaeassoci
pneumonia
haemophilu
influenzaeassoci
pneumonia
respiratori
virusassoci
pneumonia
includ
influenzaassoci
pneumonia
guardian
requir
obtain
written
consent
particip
waiv
irb
studi
observ
natur
without
deviat
current
medic
practic
hospit
doctor
verbal
describ
studi
object
method
elig
patient
guardian
consult
also
provid
necessari
inform
patient
guardian
use
standard
questionnair
sheet
poster
present
outpati
depart
anonym
data
use
analysi
accord
nation
statist
total
popul
japan
million
popul
year
age
year
age
although
nation
recommend
polysaccharid
pneumococc
vaccin
exist
time
studi
cost
partial
fulli
subsid
local
govern
estim
coverag
rate
adult
age
year
approxim
studi
conduct
four
communitybas
hospit
four
prefectur
hokkaido
chiba
kochi
nagasaki
japan
septemb
januari
one
hospit
locat
four
main
island
ebetsu
citi
hospit
hokkaido
kameda
medic
center
honshu
chikamori
hospit
shikoku
juzenkai
hospit
kyusyu
japan
univers
health
insur
system
medic
cost
peopl
age
year
medic
cost
peopl
age
year
cover
regardless
whether
individu
treat
privat
public
sector
therefor
assum
characterist
pneumonia
patient
visit
hospit
significantli
differ
visit
neighbor
hospit
outpati
screen
hospit
physician
elig
patient
identifi
use
standard
case
definit
patient
fulfil
follow
criteria
enrol
studi
age
year
symptom
compat
pneumonia
eg
fever
cough
sputum
pleurit
chest
pain
dyspnea
new
pulmonari
infiltr
chest
xray
cxr
comput
tomographi
ct
scan
film
consist
pneumonia
ensur
elig
case
enrol
studi
investig
screen
hospit
databas
intern
classif
diseas
revis
code
review
hospit
medic
record
enrol
case
classifi
cap
hcap
group
accord
definit
atsidsa
guidelin
patient
develop
diseas
hour
admiss
classifi
hap
exclud
repeat
episod
pneumonia
patient
within
period
regard
singl
episod
demograph
clinic
inform
collect
patient
medic
chart
use
standard
data
collect
form
sputum
blood
sampl
collect
particip
admiss
sputum
induc
inhal
hyperton
salin
solut
patient
unabl
cough
sputum
cxr
taken
patient
within
hour
admiss
ct
scan
order
clinician
base
judgment
clinic
specimen
immedi
transport
laboratori
hospit
gram
stain
perform
sputum
specimen
specimen
qualiti
evalu
train
laboratori
technician
accord
miller
jone
classif
sputum
sampl
examin
use
semiquantit
quantit
cultur
method
sputum
sampl
test
institut
tropic
medicin
nagasaki
univers
use
inhous
multiplex
polymeras
chain
reaction
pcr
assay
identifi
bacteri
viral
pathogen
three
typic
bacteri
pathogen
pneumonia
h
influenza
catarrhali
three
atyp
bacteri
pathogen
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
thirteen
viral
pathogen
also
perform
urinari
antigen
test
pneumonia
l
pneumophila
use
commerci
kit
binax
streptococcu
pneumonia
binax
legionella
aler
inc
waltham
usa
pneumococc
isol
serotyp
use
capsular
quell
method
etiolog
categori
pneumonia
defin
accord
microbiolog
find
sputum
blood
urin
sampl
caus
pathogen
determin
hospit
clinician
studi
investig
cultur
pcr
rapid
urin
test
perfect
estim
preval
pneumonia
h
influenza
use
two
differ
method
posit
defin
either
sputum
cultur
urinari
antigen
test
show
posit
result
standard
estim
posit
defin
sputum
cultur
sputum
pcr
urinari
antigen
test
show
posit
result
maximum
estim
estim
etiologyspecif
incid
pneumonia
aspirationassoci
pneumonia
defin
independ
microbiolog
profil
case
classifi
aspirationassoci
pneumonia
patient
follow
known
risk
factor
episod
aspir
presenc
dysphagia
conscious
disturb
neuromuscular
diseas
cerebrovascular
diseas
tube
feed
bedridden
statu
preval
aspirationassoci
pneumonia
calcul
separ
pathogenspecif
categori
agegroup
specif
incid
rate
pneumonia
hospit
death
four
prefectur
estim
use
surveil
data
nation
statist
use
pneumoniaoutpati
ratio
por
base
estim
model
use
previou
studi
model
number
age
groupspecif
pneumonia
case
estim
use
age
groupspecif
number
outpati
age
groupspecif
por
por
calcul
hospit
clinic
separ
model
use
estim
number
pneumonia
outpati
visit
follow
c
ijk
annual
number
outpati
report
patient
survey
age
group
prefectur
j
facil
type
k
k
hospit
k
clinic
ijk
ratio
confirm
pneumonia
patient
number
total
outpati
age
group
prefectur
j
facil
type
k
p
ij
popul
age
group
prefectur
j
c
ijk
obtain
patient
survey
conduct
mhlw
survey
conduct
hospit
clinic
one
design
date
set
hospit
one
three
day
octob
p
ij
obtain
nation
demograph
survey
proport
pneumonia
case
among
outpati
hospit
calcul
surveil
data
estim
proport
pneumonia
case
among
outpati
clinic
obtain
clinic
databas
two
clinic
nagasaki
citi
pneumonia
diagnosi
confirm
use
case
definit
ident
use
hospitalbas
surveil
estim
age
group
use
curv
fit
agestandard
rate
calcul
use
world
standard
popul
number
pneumonia
case
entir
japanes
popul
estim
assum
incid
rate
ij
constant
across
prefectur
studi
period
total
patient
visit
studi
hospit
patient
enrol
studi
exclud
case
meet
criteria
patient
elig
analysi
see
supplementari
materi
fig
ct
scan
administ
patient
includ
demonstr
infiltr
cxr
demograph
clinic
characterist
enrol
case
shown
tabl
fiftynin
percent
patient
male
median
age
year
rang
seventyf
percent
patient
elderli
peopl
age
year
age
year
case
fatal
rate
seventytwo
percent
case
hospit
case
like
male
older
smoker
classifi
hcap
like
underli
condit
aspirationassoci
condit
sever
condit
like
visit
hospit
earli
like
fatal
outcom
compar
outpati
among
sputum
sampl
test
use
convent
cultur
caus
bacteri
pathogen
isol
sampl
monoclon
polyclon
tabl
h
influenza
common
bacteri
pathogen
isol
follow
pneumonia
h
influenza
frequent
isol
outpati
case
staphylococcu
aureu
klebsiella
pneumonia
escherichia
coli
frequent
isol
hospit
case
among
sputum
sampl
test
use
multiplex
pcr
posit
bacteri
pathogen
posit
pneumonia
posit
h
influenza
h
influenza
pneumonia
frequent
detect
sampl
outpati
case
hospit
case
pneumonia
isol
blood
cultur
n
case
pneumonia
urinari
antigen
detect
n
taken
togeth
sampl
posit
pneumonia
either
cultur
pcr
urinari
antigen
test
among
pneumonia
isol
serotyp
serotyp
domin
n
follow
serotyp
n
n
cover
serotyp
cover
pneumococc
conjug
vaccin
see
supplementari
materi
fig
multiplex
pcr
use
test
sputum
sampl
rv
sampl
posit
least
one
rv
tabl
hrv
lead
viru
identifi
follow
infa
rsv
posit
rate
rv
similar
outpati
case
hospit
case
among
sputum
sampl
test
viral
bacteri
pcr
posit
among
patient
aspirationassoci
condit
ie
aspirationassoci
pneumonia
episod
aspir
dysphagia
conscious
disturb
neuromuscular
diseas
cerebrovascular
diseas
tube
feed
bedridden
statu
among
sputum
sampl
avail
aspirationassoci
pneumonia
staphylococcu
aureu
common
bacteri
pathogen
isol
cultur
follow
pneumonia
klebsiella
pneumonia
see
supplementari
materi
tabl
pneumonia
h
influenza
less
frequent
detect
sampl
aspirationassoci
pneumonia
nonaspirationassoci
pneumonia
cultur
pcr
burden
cop
overal
annual
incid
rate
adult
pneumonia
four
prefectur
per
py
ci
per
py
japan
asr
tabl
incid
rate
highest
kochi
per
py
lowest
chiba
pneumonia
per
py
asr
differ
significantli
prefectur
rang
per
py
see
supplementari
materi
tabl
rate
higher
male
femal
vs
per
py
age
group
vs
per
py
peopl
age
year
lowest
age
year
per
py
increas
sharpli
age
becam
highest
popul
age
year
per
py
ci
fig
ageassoci
increas
rate
appar
male
femal
point
estim
rate
ratio
compar
male
femal
peopl
age
year
year
year
year
respect
increas
trend
also
observ
pneumoniarel
hospit
inhospit
death
etiologyspecif
incid
estim
etiologyassoci
incid
rate
calcul
accord
age
group
tabl
although
aspirationassoci
pneumonia
highest
incid
substanti
number
infectionassoci
pneumonia
case
among
older
peopl
pneumonia
h
influenza
rvassoci
pneumonia
follow
except
atyp
pneumonia
incid
atyp
bacteriaassoci
pneumonia
highest
among
younger
peopl
age
year
studi
popul
case
posit
blood
cultur
indic
incid
bacterem
pneumococc
pneumonia
per
py
ci
per
py
assum
proport
pneumonia
etiolog
constant
across
prefectur
estim
annual
number
cop
entir
japanes
adult
popul
case
occur
peopl
age
year
fig
seventi
percent
hospit
case
pneumonia
case
cap
among
cop
case
die
hospit
case
aspirationassoci
patient
condit
age
year
case
pneumoniaeassoci
h
influenzaeassoci
rvassoci
pneumonia
knowledg
studi
first
estim
burden
pneumonia
entir
japanes
adult
popul
overal
incid
communityonset
pneumonia
includ
cap
hcap
among
peopl
age
year
per
py
incid
sharpli
increas
age
reach
per
py
among
peopl
age
year
estim
annual
number
adult
cop
patient
japan
elderli
peopl
age
year
aspir
lead
etiolog
categori
pneumonia
though
substanti
number
case
still
associ
infect
pneumonia
find
clearli
indic
pneumonia
agerel
diseas
caus
enorm
burden
age
popul
incid
pneumonia
japanes
elderli
peopl
higher
incid
observ
largescal
populationbas
studi
unit
state
european
countri
japan
incid
cop
among
peopl
age
year
per
py
contrast
cop
incid
per
py
unit
state
per
py
spain
per
py
unit
kingdom
high
pneumonia
incid
japan
may
partial
explain
high
proport
extrem
elderli
peopl
age
year
elderli
popul
howev
trend
fundament
chang
incid
standard
use
world
standard
popul
asr
cop
among
elderli
japan
unit
state
spain
unit
kingdom
per
py
respect
inhospit
mortal
rate
cop
japan
lower
report
countri
unit
state
spain
unit
kingdom
find
suggest
patient
mild
pneumonia
case
may
overlook
countri
visit
clinic
diagnos
japan
fact
pneumonia
case
examin
ct
scan
diagnos
pneumonia
good
access
healthcar
facil
result
univers
health
coverag
wide
use
sensit
diagnost
tool
may
explain
high
incid
howev
indic
hospit
case
japan
milder
countri
proport
sever
case
score
current
studi
compar
unit
kingdom
spain
pneumonia
incid
inhospit
moral
higher
among
male
among
femal
especi
among
older
age
group
confirm
previou
work
consid
higher
incid
childhood
pneumonia
among
male
may
genet
vulner
pneumonia
howev
evid
support
hypothesi
accord
estim
aspir
lead
caus
pneumonia
burden
pneumonia
associ
aspir
higher
associ
singl
pathogen
includ
pneumonia
burden
particularli
high
among
elderli
popul
aspirationassoci
pneumonia
case
occur
patient
age
year
inhospit
mortal
aspirationassoci
pneumonia
higher
pneumonia
categori
aspirationassoci
pneumonia
overlook
current
pneumonia
control
program
although
previou
studi
shown
condit
common
among
hospit
pneumonia
patient
burden
never
evalu
popul
level
past
aspirationassoci
pneumonia
multifactori
condit
observ
older
peopl
impair
swallow
abnorm
cough
reflex
increas
risk
oropharyng
aspir
aspir
colon
pathogen
gastric
acid
caus
lower
respiratori
tract
infect
andor
lung
injuri
compromis
immun
comorbid
chang
lung
function
age
group
underli
condit
associ
high
mortal
nurs
home
resid
high
risk
aspir
hcap
aspirationassoci
pneumonia
ident
condit
fact
studi
cap
hcap
case
associ
aspir
effect
clinic
manag
prevent
measur
target
aspirationassoci
pneumonia
remain
underdevelop
at
guidelin
recommend
use
inhibitor
condit
manag
recurr
refractori
case
challeng
prevent
oral
hygien
care
dysphagia
rehabilit
suggest
reduc
risk
aspir
pneumonia
limit
support
evid
burden
aspirationassoci
pneumonia
may
increas
number
elderli
peopl
requir
longterm
care
increas
effect
clinic
public
health
intervent
measur
urgent
need
current
studi
pneumonia
lead
singl
etiolog
pathogen
associ
pneumonia
confirm
previou
report
recent
studi
japan
shown
posit
pneumonia
among
cap
case
accord
recent
metaanalysi
proport
pneumococc
pneumonia
among
cap
case
proport
pneumococc
pneumonia
among
pneumonia
case
declin
highincom
countri
reflect
wide
use
antibiot
pneumococc
vaccin
studi
posit
pneumonia
sputum
cultur
consid
low
sensit
sputum
cultur
includ
urinari
antigen
testposit
case
standard
estim
includ
pcrposit
case
maximum
estim
true
valu
must
lie
valu
ie
proport
bacteremia
among
pneumococc
pneumonia
case
studi
metaanalysi
show
approxim
pneumococc
pneumonia
bacterem
figur
lower
estim
howev
result
show
incid
bacterem
pneumococc
pneumonia
among
japanes
adult
per
py
figur
compar
report
countri
unit
state
australia
find
suggest
pneumococc
pneumonia
either
bacterem
nonbacterem
remain
lead
target
pneumonia
control
program
japan
reduc
risk
invas
pneumococc
diseas
ipd
among
adult
howev
effect
pneumococc
pneumonia
still
controversi
particularli
elderli
recent
approv
expect
prevent
almost
half
pneumococc
pneumonia
case
elderli
howev
vaccin
cover
serotyp
pneumococcu
longterm
effect
remain
unknown
japan
introduct
children
ipd
isol
serotyp
serotyp
current
studi
isol
serotyp
serotyp
vaccin
polici
pneumococcu
dramat
chang
japan
children
replac
late
also
includ
ministri
health
labour
welfar
recommend
vaccin
elderli
peopl
late
proport
vaccinecov
serotyp
known
declin
widespread
use
pcv
thu
figur
decreas
come
year
true
efficaci
adult
pneumonia
among
japanes
popul
must
evalu
along
costeffect
analys
introduc
nation
immun
program
substanti
proport
pneumonia
associ
rv
pneumonia
case
recent
studi
suggest
rv
play
crucial
role
develop
pneumonia
includ
sever
case
howev
biolog
mechan
remain
larg
unknown
rv
influenza
rsv
human
metapneumoviru
hmpv
caus
outbreak
among
elderli
nurs
home
rv
potenti
target
vaccin
current
season
influenza
vaccin
avail
adult
effect
pneumonia
prevent
yet
establish
investig
need
clarifi
public
health
impact
rvassoci
pneumonia
age
societi
find
import
implic
effect
pneumonia
control
program
age
societi
burden
pneumonia
higher
older
peopl
pneumonia
etiolog
larg
vari
age
group
incid
aspir
pneumonia
h
influenza
rv
pdr
pathogenassoci
pneumonia
increas
age
incid
atyp
bacteriaassoci
pneumonia
decreas
must
note
proport
pneumonia
caus
unknown
pathogen
higher
among
elderli
peopl
categori
like
repres
multifactori
condit
therefor
come
decad
pneumonia
burden
like
increas
etiolog
becom
divers
situat
current
etiologyspecif
approach
ie
vaccin
pneumococcu
influenza
guidelin
appropri
antibiot
use
must
limit
impact
multidimension
approach
integr
vaccin
program
clinic
manag
guidelin
train
health
care
worker
educ
peopl
must
need
studi
warrant
studi
first
estim
nation
burden
cop
japan
although
pneumonia
common
diseas
true
burden
remain
unclear
even
highincom
countri
number
studi
report
incid
adult
pneumonia
estim
substanti
vari
set
set
sever
factor
explain
variat
first
definit
pneumonia
differ
among
studi
studi
report
incid
cap
includ
outpati
hospit
patient
studi
report
hospit
case
clear
whether
studi
includ
hcap
case
addit
diagnosi
pneumonia
standard
clinic
set
thu
burden
estim
base
exist
databas
unreli
second
studi
design
vari
pneumonia
common
diseas
includ
nation
surveil
cohort
studi
may
repres
entir
popul
countri
hospitalbas
studi
captur
case
commun
differ
design
may
produc
differ
estim
ident
popul
third
health
careseek
pattern
affect
incid
estim
mild
case
must
overlook
countri
access
health
care
limit
current
studi
enrol
pneumonia
case
prospect
confirm
studi
clinician
use
standard
case
definit
consid
high
reliabl
nation
statist
japan
estim
reason
assum
reflect
true
pneumonia
burden
among
japanes
adult
studi
limit
incid
estim
assum
pneumoniaoutpati
ratio
studi
hospit
constant
across
hospit
four
prefectur
addit
calcul
nation
burden
assum
incid
cop
four
prefectur
constant
across
prefectur
hospit
communitybas
gener
hospit
provid
primari
secondari
tertiari
care
resid
thu
patient
visit
hospit
reflect
gener
popul
fact
asr
four
prefectur
almost
ident
studi
furthermor
accord
nation
patient
survey
proport
report
acut
respiratori
infect
among
outpati
four
prefectur
ident
nation
averag
see
supplementari
materi
believ
assumpt
reason
contrast
consid
season
differ
pneumonia
etiolog
etiologyspecif
burden
estim
must
confirm
use
multiyear
surveil
data
studi
aspirationassoci
pneumonia
defin
base
presenc
known
risk
factor
thu
could
distinguish
aspir
pneumonia
caus
aspir
colon
oropharyng
pathogen
aspir
pneumon
caus
aspir
gastric
content
howev
reliabl
marker
identifi
aspir
studi
need
better
defin
pneumonia
categori
substanti
portion
cop
burden
japanes
adult
popul
occur
elderli
aspir
lead
etiolog
pneumonia
follow
pneumonia
addit
introduct
vaccin
pneumonia
influenza
multidimension
approach
urgent
need
reduc
pneumonia
burden
age
societi
support
inform
databas
databas
communityonset
pneumonia
case
tabl
microbiolog
profil
patient
communityonset
pneumonia
without
aspirationassoci
condit
docx
